BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/23/2026 11:05:52 AM | Browse: 1 | Download: 7
 |
Received |
|
2025-10-11 09:47 |
|
Peer-Review Started |
|
2025-10-11 09:47 |
|
First Decision by Editorial Office Director |
|
2025-11-05 08:14 |
|
Return for Revision |
|
2025-11-05 08:14 |
|
Revised |
|
2025-11-19 02:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-02 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-02 07:16 |
|
Articles in Press |
|
2026-02-02 07:16 |
|
Edit the Manuscript by Language Editor |
|
2026-02-05 03:01 |
|
Typeset the Manuscript |
|
2026-03-30 12:16 |
|
Publish the Manuscript Online |
|
2026-04-23 11:05 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Randomized controlled trial of Danggui Sini Decoction in the treatment of lower limb arteriosclerosis obliterans
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan-Bo Fu, Feng Yan, Hong-Jiang Zhu and Cong Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| 2023 Zhangjiajie Municipal Special Fund for Sci-Tech Development |
No. 7 |
|
| Corresponding Author |
Hong-Jiang Zhu, MD, Department of Vascular Interventional Surgery, Zhangjiajie People’s Hospital, No. 192 Guyong Road, Yongding District, Zhangjiajie 415000, Hunan Province, China. 13028176178@163.com |
| Key Words |
Arteriosclerosis obliterans; Danggui Sini Decoction; Endovascular revascularization; Clinical efficacy; Primary patency rate; Quality of life; Target lesion revascularization |
| Core Tip |
This randomized controlled trial demonstrates that adjunctive therapy with Danggui Sini Decoction (DGSD), a classic traditional Chinese medicine formula, significantly enhances the long-term outcomes of endovascular revascularization for arteriosclerosis obliterans. At six months, the DGSD group showed superior clinical effectiveness (94.74% vs 73.68%) and primary patency rates compared to the control group. The combination therapy also led to a greater improvement in quality of life, suggesting DGSD is a valuable complementary treatment for improving vascular patency and patient well-being in arteriosclerosis obliterans management. |
| Publish Date |
2026-04-23 11:05 |
| Citation |
Fu YB, Yan F, Zhu HJ, Wang C. Randomized controlled trial of Danggui Sini Decoction in the treatment of lower limb arteriosclerosis obliterans. World J Methodol 2026; 16(2): 115003 |
| URL |
https://www.wjgnet.com/2222-0682/full/v16/i2/115003.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v16.i2.115003 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
